120 related articles for article (PubMed ID: 2046411)
1. [Immunoglobulin A and human immunodeficiency virus type 1 infection in parenteral drug abuse addicts].
Muga R; Tor J; Solsona L; Villanueva C; Pol M; Jacas C; Sabriá M; Rey-Joly C; Foz M
Med Clin (Barc); 1991 Mar; 96(10):361-3. PubMed ID: 2046411
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 IgA specific serum antibodies and disease progression during HIV-1 infection.
Margalith M; Levy E; Rinaldo CR; Detels R; Phair J; Kaslow R; Saah AJ; Sarov B
J Hum Virol; 2001; 4(5):269-77. PubMed ID: 11907384
[TBL] [Abstract][Full Text] [Related]
3. [Seroepidemiologic study of human herpesvirus-6 in intravenous drug addicts, with and without infection caused by human immunodeficiency virus type 1].
Lozano de León F; Iglesias C; Lucio-Villegas ME; Lozano MC; Corzo JE; Martín-Mazuelos E; García-Bragado F
Med Clin (Barc); 1992 Jul; 99(6):210-2. PubMed ID: 1324385
[TBL] [Abstract][Full Text] [Related]
4. [Dyslipemia and HIV-1 infection in intravenous drug addicts].
Muga R; Tor J; Rey-Joly C; Pardo A; Llobet P; Foz M
Med Clin (Barc); 1993 Feb; 100(5):161-3. PubMed ID: 8450692
[TBL] [Abstract][Full Text] [Related]
5. [An epidemiological and immunological study of human immunodeficiency virus infection in the southern area of Madrid].
Cervero M; Medina Asensio J; Rubio R; Costa JR
Rev Clin Esp; 1991 Jan; 188(1):17-23. PubMed ID: 2063023
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of infection by the human immunodeficiency virus type 1 in drug addicts in Madrid, over a 5 year period].
Sopelana P; Diéguez A; Bautista L
Med Clin (Barc); 1991 Nov; 97(16):601-3. PubMed ID: 1766279
[TBL] [Abstract][Full Text] [Related]
7. Serum IgD behaviour in HIV-1 infected patients.
Raiteri R; Albonico M; Deiana R; Marietti G; Sinicco A
Allergol Immunopathol (Madr); 1991; 19(1):6-10. PubMed ID: 1950942
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and prognostic significance of anti-HTLV-I and anti-HIV-2 antibodies in patients with HIV infection in the Roman region].
Antinori A; Tamburrini E; Ventura G; Nervo P; Ortona L
Boll Ist Sieroter Milan; 1988; 67(5-6):345-50. PubMed ID: 2908738
[TBL] [Abstract][Full Text] [Related]
9. Serum albumin and others parameters in intravenous drug users HIV-infected.
Cirasino L; Landonio G; Imbriani M; Silvani A; Bighellini K; Ragaini S
Recenti Prog Med; 1992 Jun; 83(6):344-9. PubMed ID: 1496183
[TBL] [Abstract][Full Text] [Related]
10. Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men.
Margalith M; Sarov B; Sarov I; Rinaldo C; Detels R; Phair J; Kaslow R; Ginsberg H; Saah A
AIDS Res Hum Retroviruses; 1990 May; 6(5):607-16. PubMed ID: 2193673
[TBL] [Abstract][Full Text] [Related]
11. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
12. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
13. Neurological and neuropsychological manifestations of HIV-1 infection: association with AIDS-related complex but not asymptomatic HIV-1 infection.
Janssen RS; Saykin AJ; Cannon L; Campbell J; Pinsky PF; Hessol NA; O'Malley PM; Lifson AR; Doll LS; Rutherford GW
Ann Neurol; 1989 Nov; 26(5):592-600. PubMed ID: 2817835
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.
Moja P; Tranchat C; Tchou I; Pozzetto B; Lucht F; Desgranges C; Genin C
J Infect Dis; 2000 May; 181(5):1607-13. PubMed ID: 10823760
[TBL] [Abstract][Full Text] [Related]
15. [Infection by the human immunodeficiency virus type 1 in the population of prisoners of Catalonia].
Bayas JM; Martín V; Vidal J; Pumarola T; Jiménez de Anta MT; Salleras L
Med Clin (Barc); 1994 Feb; 102(6):209-12. PubMed ID: 8159054
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of human immunodeficiency virus type 1 and Mycobacterium tuberculosis infections in a prison population in the years 1989 to 1995].
Pérez-Agudo F; Alonso Moreno FJ; Urbina Torija J
Med Clin (Barc); 1998 Feb; 110(5):167-70. PubMed ID: 9547719
[TBL] [Abstract][Full Text] [Related]
17. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of HIV-1 infection in intravenous drug dependent patients 1986 to 1989 in Vienna].
Loimer N; Presslich O; Hollerer E; Werner E; Pakesch G; Pfersmann V; Schmid-Siegel B; Aschauer G
Wien Klin Wochenschr; 1990 Feb; 102(4):106-10. PubMed ID: 2316224
[TBL] [Abstract][Full Text] [Related]
19. Relationship of serum immunoglobulin and IgG subclass levels to race, ethnicity and behavioral characteristics in HIV infection.
McGowan JP; Shah SS; Small CB; Klein RS; Schnipper SM; Chang CJ; Rosenstreich DL
Med Sci Monit; 2006 Jan; 12(1):CR11-16. PubMed ID: 16369464
[TBL] [Abstract][Full Text] [Related]
20. The spread of HIV-1 infection in Italy: seropositivity and AIDS related syndromes.
Luzi G; Greco D; Sasse H; Rezza G; Aiuti F
Allergol Immunopathol (Madr); 1991; 19(1):19-24. PubMed ID: 1950940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
